Celgene Corp.

Pharmaceuticals
United States
2016 Revenue (US$ Millions)$11,229
Revenue Growth (%)21.32%
Net Income (US$ Millions)$1,999
Earnings Per Share (US$)$2.49
EPS Growth Rate (%)28.35%
Profit Margin17.80%
Total Equity (US$ Millions)$6,599
Return on Equity (%)33.78%
Long Term Debt (US$ Millions)$13,789
Debt To Equity Ratio (%)2.09%
Total Assets (US$ Millions)$28,086
Current Assets (US$ Millions)$10,868
Current Liabilities (US$ Millions)$2,959
Cost of Goods Sold (US$ Millions)$438
Inventory Turnover0.93